Childhood vaccine linked to less severe Covid-19, cigarette smoke raises risk
Covid-19 reinfection unlikely for at least six months, study finds
T-cell abnormalities in severe COVID-19 cases
Pfizer Expected to File FDA EUA Application for COVID-19 Vaccine Today
Antibody cocktails at low doses could be more effective at treating COVID-19
UPDATED: Eli Lilly's Covid-19 partner AbCellera pays $90M for some very special mice as Peter Thiel jumps on the board and IPO rumors heat up
Coronavirus vaccine results are pouring in, and it's good news for older people
Eli Lilly's Covid-19 partner AbCellera pays $90M for some very special mice as IPO rumors heat up
In the lab, St. Jude scientists identify possible COVID-19 treatment
COVID-19 vaccines: How Pfizer's and Moderna's 95% effective mRNA shots work
Pfizer In Regular Contact With Biden Campaign, Expects To Seek Vaccine Emergency Approval Friday
Analysis: Can first Covid-19 vaccines bring herd immunity? Experts have doubts
How mRNA vaccines from Pfizer and Moderna work, why they're a breakthrough and why they need to be kept so cold
Kids mount a COVID-19 immune response without detection of the SARSCoV- 2 virus
U.S. hospitals to restrict Lilly Covid-19 antibody treatment due to limited supply
Covid-19 roundup: EU begins reviewing Moderna vaccine; CureVac and EU agree to 405M-dose deal
Virus evolution could undermine a COVID-19 vaccine – but this can be stopped
Covid-19 roundup: CureVac and EU agree to 405M-dose deal; WHO warns that vaccine news is no panacea
Pfizer begins US pilot delivery programme for COVID-19 vaccine
BioNTech, Fosun Pharma Get Green Light To Start Covid-19 Vaccine Trial In China
Stocks Hit New 52-Week On Moderna’s Coronavirus Vaccine Results
Here's How The Pfizer And Moderna Vaccines Stack Up
J&J Secures Additional $1 Billion in Funding for Covid-19 Vaccine
Researchers find coronavirus was circulating in Italy earlier than believed
Moderna’s COVID-19 vaccine has a 94.5 percent effective rate
What monoclonal antibodies are – and why we need them as well as a vaccine
Roche’s Herceptin/Perjeta combo product nears EU approval
A Pop In "Value", But Still Not A Sustainable "Value" Rotation
Prospect of a Vaccine Signals a New Game is Afoot
Pfizer, Moderna Results Leave Many Important Questions Unanswered